Moderna Starts COVID Vaccine Study For Children Under 12
CAMBRIDGE (CBS) – Moderna has started a study of its coronavirus vaccine in children under the age of 12.
The Cambridge-based company announced Tuesday that the first participants in the research – ages 6 months to less than 12 years – have received doses.
The two-part study is designed to show how children tolerate the vaccine, and to make sure it’s safe and effective for them. This expands the age bracket of Moderna’s study which started with kids ages 12 to
Read more »